Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 51,578 |
|
|||||
| News | - | ||||||
| Day High | 1.28 | Low High |
|||||
| Day Low | 1.22 | ||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| Advisorshares Psychedelics ETF | PSIL | AMEX | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| 0.045 | 3.50% | 1.33 | 17:31:30 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.28 | 1.22 | 1.28 | 1.26 | 1.285 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 268 | 51,578 | 1.26 | 64,771 | - | 1.20 - 2.249 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 785 | 1.26 | USD |
Advisorshares Psychedelics ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.47M | - | - | - | 50.62 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Advisorshares Psychedeli...
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
PSIL Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.29 | 1.32 | 1.22 | 1.30 | 49,683 | 0.04 | 3.10% |
| 1 Month | 1.44 | 1.464 | 1.20 | 1.30 | 58,108 | -0.11 | -7.64% |
| 3 Months | 1.45 | 1.70 | 1.20 | 1.45 | 74,278 | -0.12 | -8.28% |
| 6 Months | 1.35 | 1.70 | 1.20 | 1.44 | 61,608 | -0.02 | -1.48% |
| 1 Year | 1.76 | 2.249 | 1.20 | 1.55 | 46,832 | -0.43 | -24.43% |
| 3 Years | 10.10 | 10.70 | 1.20 | 2.83 | 34,312 | -8.77 | -86.83% |
| 5 Years | 10.10 | 10.70 | 1.20 | 2.83 | 34,312 | -8.77 | -86.83% |
| The AdvisorShares Psychedelics ETF (the Fund) seeks long-term capital appreciation. The Fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in (i) securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and (ii) derivatives that have economic characteristics similar to such securities. The Fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The Fund invests in exchange-listed equity securities, including common and preferred stock of U.S. and foreign mid, small and micro-capitalization companies, and in total return swaps intended to provide exposure to such companies. |
